Product or Products Sample Clauses

Product or Products. 7 1.13 Printer Specifications ..........................................7 1.14
Sample 1Sample 2
AutoNDA by SimpleDocs
Product or Products. 3 1.21 Promotional Guidelines..................................................................................... 3 1.22
Sample 1
Product or Products. The drug substance (for the manufacturing of the Drug Product Zadaxin®) which will be manufactured, tested, stored, and shipped by Lonza for SPIL. Quality Agreement An addendum to the Supply Agreement which outlines the GMP roles and responsibilities of each Party (SPIL and Lonza) for the Manufacturing of Product Quality Assurance The sum total of the organized arrangements made with the objective of ensuring that all Products meet the quality required for their intended use and that the quality systems are maintained. Quality Control The sampling, setting of Specifications, testing, documentation and Analytical Methods that provide independent results of required tests, which contribute to the evaluation of the quality of a material. Quality Unit An organizational unit independent of production that performs both Quality Assurance and Quality Control Responsibilities. This can be in the form of separate QA and QC units or a single unit. Qualified Person The person at Lonza who is responsible for the Manufacturer's Release of Product, who prepares and approves the COC. Raw Data Any original laboratory worksheets, records, memoranda, note, document, or exact copies thereof, which are the result of original observations that are necessary for reconstruction and evaluation of processing, QuaHty Control or Quality Assurance activities. Raw data may include photographs, microfilm or microfiche copies, computer printouts, magnetic media, including dictated observations, and recorded data from automated instruments. Raw Materials Materials, excipients, components (processing aids such as tubing/filters), reagents, solvents needed for the production of Product. 61 *** CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN PORTIONS OF THIS EXHIBIT. CONFIDENTIAL PORTIONS OF THIS EXHIBIT ARE DESIGNATED BY [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Reasonable Effort, Commercially Reasonable Effort, or Reasonable Efforts and resources comparable to those that would be employed dedicating the highest level of skill, care, efforts and resources to the Commercial Production of the applicable Bulk Drug Substance, including meeting the deadlines and 1 milestones herein, and, except as otherwise provided for herein, dedicating the highest priority to obtaining approval by regulatory authorities and commencing Commercial Production of the applicable Bulk Drug Substance or Product. Recall Tracing and recovery...
Sample 1
Product or Products. As used herein, the term "Product" or "Products" shall mean all products and services offered for sale or lease by ECOX that are currently owned or hereafter purchased, developed or otherwise offered for sale or lease by ECOX, using IP TRUST intellectual property. Currently IP TRUST offers products in the following:
Sample 1
Product or Products. Product or Products shall mean any or all products manufactured or distributed by COMPANY intended for use in the educational, training environment.
Sample 1
Product or Products. “Product” or “Products” means SBS’ Open File Manager software application and SBS’ Continuous Data Protection software application and any and all derivative product technologies related thereto, including, without limitation, all other software, programs, applications, modules and components thereof, in all forms, including the Source Code, Object Code, all related documentation, all prior and current versions, improvements, enhancements, upgrades, corrections, additions, modifications, replacements, and new applications to any of the foregoing (including, for avoidance of doubt, DeploySafe and MARS); and all Intellectual Property Rights in any of the foregoing. In no event shall “Product” include SBS’ on-demand service, iPrism and/or ePrism products, nor any open source materials or software included in or used with the Product. To the extent that the Product contains code that is also included in other SBS products relating to non-core functionality, such as for license key generation and other administrative functions associated with use of the Product, notwithstanding any provision in this Agreement to the contrary, SBS retains all Intellectual Property Rights to such code and grants to Buyer a perpetual, non-exclusive, irrevocable license to continue to use, distribute, and make derivative copies of such code as part of the Product.
Sample 1

Related to Product or Products

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • Product The term “

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.

  • Supply of Products TheraSense shall be responsible for the ------------------ manufacture of FreeStyle Products for sale to Nipro.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

Time is Money Join Law Insider Premium to draft better contracts faster.